📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
0 articles
AVG GRADE
—
SENTIMENT
NEUTRAL
TOTAL VIEWS
0
RECENT COVERAGE · 4 ARTICLES
Absci: Eli Lilly Backs Alopecia Data With Funding, But Risks Remain (NASDAQ:ABSI)
ABSI rallied 30% on the back of a $100M equity investment from pharmaceutical heavyweight Eli Lilly, signaling institutional validation...
Absci Corp Stock Rises 18% After Positive Phase 1 Data For AI-Designed Drug Candidate
ABSI delivered an 18.8% single-day gain following positive interim Phase 1 data for ABS-201, marking a validation inflection for...
6 Biotech Stocks That Delivered Stunning Gains: INBX +700%, PVLA +500%, MBX +300%, ABSI +200% & More
This article profiles six biotech stocks exhibiting exceptional multi-year performance, with INBX leading at +700% and PVLA at +500%....
Leerink Starts Coverage on Absci Corporation (ABSI)
Leerink's initiation of coverage on ABSI with an Outperform rating represents a positive validation signal for the biotech/AI-driven...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice